Sign in

CIK 0001953926

  • Emerging growth company

Zenas BioPharma, Inc.

Sign in to watch
Ticker
ZBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-271-2954
Business address
852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
Former names
Zenas BioPharma (Cayman) Ltd
  1. 4 Open-market buy Director bought 19,860 shares at an average $25.16 ($499,746)
  2. 4 Open-market buy Chief Executive Officer bought 57,000 shares at $17.96 ($1,023,720)
  3. 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $16.39 ($1,639,000)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 63,158 shares at $19.00 ($1,200,002)
  6. 4 Open-market buy 10% owner bought 126,315 shares at $19.00 ($2,399,985)
  7. 4 Open-market buy Director bought 117,255 shares at an average $19.19 ($2,250,027)
  8. 4 Open-market buy MOULDER LEON O JR bought 36,928 shares at $20.85 ($769,949)
  9. 4 Open-market buy Director bought 316,219 shares at $19.00 ($6,008,161)
  10. 4 Open-market buy Director bought 321,983 shares at an average $18.63 ($6,000,031)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 5 · 84 filings